A Pharmacist-Built System Replaces Paper Logs for Surgical Centers

Founder Jon Lim built the software after seeing consultants rely on paper. Now he's betting ASCs will pay for pharmacist-oriented compliance.

About TOM Pharmacy

Published

In the world of ambulatory surgery, where efficiency is measured in minutes between procedures, medication management often still runs on paper. It is a critical, regulated process that can hinge on a handwritten temperature log or a controlled-substance spreadsheet, vulnerable to human error and regulatory scrutiny. TOM Pharmacy, a quiet startup from Austin, is betting that the pharmacist, not just the administrator, should be at the center of that digital transition.

Founded in 2022 by pharmacist Jon Lim, the company is building what it calls medication management infrastructure specifically for ambulatory surgery centers (ASCs). The product is a software system designed to replace paper-based logs and operational processes with tools built for pharmacy professionals. For Lim, the insight was personal, born from seeing consultants in the field still relying on manual methods. "The company says it was founded after its pharmacist founder encountered a consultant still using paper logs, prompting him to build a system 'pharmacists use to run the work,'" according to the company's public materials [TOM Pharmacy, retrieved 2026].

A solo founder's clinical wedge

The company's trajectory is intimately tied to its founder's hands-on experience. Jon Lim, a PharmD, has not only designed the software but also funded its development through direct clinical work. His public profile states he provided overnight pharmacist coverage from July 2025 to July 2026 while bootstrapping TOM, handling clinical decisions, patient safety, and controlled-substance accountability [LinkedIn, retrieved 2026]. This grounding in the nightly realities of pharmacy operations informs the product's focus. It aims to address core compliance and safety workflows that are table stakes for ASCs seeking accreditation from bodies like CMS.

The software surfaces, as described on the company's website, include a dashboard, controlled substance (CS) logs, environmental monitoring for temperature and humidity, a pharmacist verification queue, a compliance score, and a diversion risk indicator [TOM Pharmacy, retrieved 2026]. This feature set targets the precise pain points of medication accountability in a high-turnover surgical setting.

Founder Role Key Background
Jon Lim Founder & CEO PharmD; led overnight pharmacy operations while bootstrapping the company; leads product strategy and workflow design [LinkedIn, retrieved 2026].

The market of paper and pressure

Ambulatory surgery centers represent a growing segment of the healthcare delivery system, prized for lower costs and patient convenience. However, their pharmacy operations are often lean, sometimes managed by a single pharmacist or an external consultant. The regulatory environment is stringent, with surveys focusing on perfect documentation for everything from crash cart medications to refrigerator temperatures. The standard technology here is frequently a patchwork of spreadsheets, paper checklists, and maybe a standalone temperature monitor.

TOM Pharmacy's bet is that a unified, pharmacist-centric platform can become a non-negotiable operational layer. By structuring previously ad-hoc data, the system promises not just compliance but preventative management,catching a refrigeration drift before it ruins thousands of dollars in medication, or flagging a pattern that could indicate diversion. The company positions itself as providing "tools, knowledge, and community for pharmacy" [TOM Pharmacy, retrieved 2026], suggesting an ambition to become a central hub for the professionals who serve this niche.

The path from bootstrap to scale

The company is listed as a pre-seed venture in startup directories [NFX, 2026], and there is no verifiable public disclosure of institutional funding. This bootstrapped, founder-led phase presents both a clarity of focus and a significant challenge. The lack of a named investor roster or a disclosed round means growth must be customer-funded and deliberate. The primary competitive risk isn't a direct, named software clone but the inertia of the existing paper-based workflow and the potential for larger, generalized healthcare IT platforms to build similar modules.

For TOM Pharmacy to succeed, it must prove that a specialist tool can command a premium and achieve deep adoption within a specific provider type. The company will need to demonstrate that its software doesn't just digitize paper, but actively improves patient safety and operational efficiency in ways that justify its cost. The next twelve months will likely be about converting early pilot centers into referenceable customers and building a commercial footprint beyond the founder's direct network.

The patient population here is not the individual undergoing surgery, but the ASC facility itself,a business entity navigating a maze of safety and financial regulations. The standard of care today is a manual, pharmacist-dependent process where accountability can be difficult to audit and errors are harder to catch proactively. It's a system built on trust and checklists, one that works until it doesn't. TOM Pharmacy is wagering that in an era of digital everything, the medication room is the next frontier for structured data, and the pharmacist should be the one holding the keys.

Sources

  1. [TOM Pharmacy, retrieved 2026] Company website and blog | https://www.tompharmacy.com/
  2. [LinkedIn, retrieved 2026] Jon Lim professional profile | https://www.linkedin.com/in/tomrx
  3. [NFX, 2026] Top 2026 Pharmaceuticals Pre-Seed Investors | https://signal.nfx.com/investor-lists/top-pharmaceuticals-pre-seed-investors

Read on Startuply.vc